News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celerion Acquires Early Stage Clinical Research Operations from MDS Pharma Services (MDZ)



3/29/2010 9:22:58 AM

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a privately owned contract research organization (CRO), has completed the acquisition of the development and regulatory services consultancy and early stage development operations of MDS Pharma Services. The acquired assets include five clinical research facilities and two bioanalytical laboratories located in Lincoln, Nebraska; Neptune, New Jersey; Phoenix, Arizona; Zurich, Switzerland; and Belfast, Northern Ireland, as well as operations in Richmond, Virginia and Quebec, Canada. With over 700 beds worldwide, Celerion is an industry leader in the conduct of early clinical research, including first-in-man to proof-of-concept clinical studies, clinical pharmacology, bioequivalence trials, bioanalysis, and cardiac safety services.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES